Skip to main content
. Author manuscript; available in PMC: 2022 Jul 1.
Published in final edited form as: JACC Cardiovasc Imaging. 2021 Jan 13;14(7):1338–1350. doi: 10.1016/j.jcmg.2020.11.006

Central Illustration. Patient examples of Fibrosis Progression and Survival Analysis.

Central Illustration.

Panel a. Patient examples. Patient 1 had no fibrosis on CMR-1, on follow-up imaging midwall fibrosis is seen in the basal septum (yellow arrows) which is a typical finding on non-ischemic DCM. Patient 2 had midwall fibrosis on CMR-1, which has progressed on CMR-2.

Panel b. The difference in overall survival in patients with progressive fibrosis and stable fibrosis was significant (p=0.03, by the log rank test). There was also a significant difference in major adverse cardiovascular event (MACE) (p<0.01, by the log rank test).